187 related articles for article (PubMed ID: 18190879)
41. Do Toll-like receptors contribute to the pathogenesis of lupus?
Youinou P
J Rheumatol; 2007 Aug; 34(8):1641-2. PubMed ID: 17696280
[No Abstract] [Full Text] [Related]
42. Interrelationship of dendritic cells, type 1 interferon system, regulatory T cells and toll-like receptors and their role in lichen planus and lupus erythematosus -- a literature review.
Trucci VM; Salum FG; Figueiredo MA; Cherubini K
Arch Oral Biol; 2013 Oct; 58(10):1532-40. PubMed ID: 23845753
[TBL] [Abstract][Full Text] [Related]
43. Innate immune response to viral infection.
Koyama S; Ishii KJ; Coban C; Akira S
Cytokine; 2008 Sep; 43(3):336-41. PubMed ID: 18694646
[TBL] [Abstract][Full Text] [Related]
44. Role of sugars in surface microbe-host interactions and immune reaction modulation.
Lloyd DH; Viac J; Werling D; Rème CA; Gatto H
Vet Dermatol; 2007 Aug; 18(4):197-204. PubMed ID: 17610483
[TBL] [Abstract][Full Text] [Related]
45. Toll-like receptors in endocrine disease and diabetes.
Kanczkowski W; Ziegler CG; Zacharowski K; Bornstein SR
Neuroimmunomodulation; 2008; 15(1):54-60. PubMed ID: 18667800
[TBL] [Abstract][Full Text] [Related]
46. Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus.
Anders HJ; Krug A; Pawar RD
Eur J Immunol; 2008 Jul; 38(7):1795-9. PubMed ID: 18581336
[TBL] [Abstract][Full Text] [Related]
47. Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori.
Rad R; Ballhorn W; Voland P; Eisenächer K; Mages J; Rad L; Ferstl R; Lang R; Wagner H; Schmid RM; Bauer S; Prinz C; Kirschning CJ; Krug A
Gastroenterology; 2009 Jun; 136(7):2247-57. PubMed ID: 19272387
[TBL] [Abstract][Full Text] [Related]
48. Toll-like receptor heterodimer variants protect from childhood asthma.
Kormann MS; Depner M; Hartl D; Klopp N; Illig T; Adamski J; Vogelberg C; Weiland SK; von Mutius E; Kabesch M
J Allergy Clin Immunol; 2008 Jul; 122(1):86-92, 92.e1-8. PubMed ID: 18547625
[TBL] [Abstract][Full Text] [Related]
49. Cytokines and the immune-neuroendocrine network: What did we learn from infection and autoimmunity?
Correa SG; Maccioni M; Rivero VE; Iribarren P; Sotomayor CE; Riera CM
Cytokine Growth Factor Rev; 2007; 18(1-2):125-34. PubMed ID: 17347025
[TBL] [Abstract][Full Text] [Related]
50. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
Fukata M; Vamadevan AS; Abreu MT
Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
[TBL] [Abstract][Full Text] [Related]
51. The immunoglobulin E-Toll-like receptor network.
Novak N; Bieber T; Peng WM
Int Arch Allergy Immunol; 2010; 151(1):1-7. PubMed ID: 19672091
[TBL] [Abstract][Full Text] [Related]
52. Differential expression and action of Toll-like receptors in human adrenocortical cells.
Kanczkowski W; Zacharowski K; Wirth MP; Ehrhart-Bornstein M; Bornstein SR
Mol Cell Endocrinol; 2009 Mar; 300(1-2):57-65. PubMed ID: 19022344
[TBL] [Abstract][Full Text] [Related]
53. Viral infection can induce the production of autoantibodies.
Barzilai O; Ram M; Shoenfeld Y
Curr Opin Rheumatol; 2007 Nov; 19(6):636-43. PubMed ID: 17917546
[TBL] [Abstract][Full Text] [Related]
54. Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settings.
Ferraccioli G; Tolusso B
Autoimmun Rev; 2007 Dec; 7(2):109-13. PubMed ID: 18035319
[TBL] [Abstract][Full Text] [Related]
55. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease.
Marshak-Rothstein A; Rifkin IR
Annu Rev Immunol; 2007; 25():419-41. PubMed ID: 17378763
[TBL] [Abstract][Full Text] [Related]
56. Autoimmunity and pathophysiology.
Tsonis IA; Avrameas S; Moutsopoulos HM
J Autoimmun; 2007 Dec; 29(4):203-5. PubMed ID: 17884336
[TBL] [Abstract][Full Text] [Related]
57. Nucleic acid-sensing TLRs as modifiers of autoimmunity.
Deane JA; Bolland S
J Immunol; 2006 Nov; 177(10):6573-8. PubMed ID: 17082566
[TBL] [Abstract][Full Text] [Related]
58. Gene/environment interactions in the pathogenesis of autoimmunity: new insights on the role of Toll-like receptors.
Gianchecchi E; Fierabracci A
Autoimmun Rev; 2015 Nov; 14(11):971-83. PubMed ID: 26184547
[TBL] [Abstract][Full Text] [Related]
59. Targeting Toll-like receptors for treatment of SLE.
Horton CG; Pan ZJ; Farris AD
Mediators Inflamm; 2010; 2010():. PubMed ID: 20886024
[TBL] [Abstract][Full Text] [Related]
60. Role of DNA/RNA sensors and contribution to autoimmunity.
Smith S; Jefferies C
Cytokine Growth Factor Rev; 2014 Dec; 25(6):745-57. PubMed ID: 25193293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
